Culture accelerates and de-risks process development, process characterization, material generation, and modeling for protein therapeutics in our cloud-connected bioreactor facility.
We have experience with CHO, HEK, Yeast, E. coli, and many other cell lines.
Clone screening for preclinical development, through process characterization for late phase development can all be run at Culture.
Analyze your product attributes with SEC and IgG titer. Monitor your process with VCD, pH, and metabolites.